CUE BIOPHARMA INC. -
1,7800
07-ноября-24 15:59:28
15 мин. задержка
Акции
+0,1300
+7,88%
Сегодняшний диапазон
1,5900 - 1,9000
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Cue Biopharma Reports First Quarter 2022 Financial Results
10 май 2022 16:30:00 Источник Nasdaq GlobeNewswire
-
Cue Biopharma to Present at the Upcoming Oppenheimer 32nd Annual Healthcare Conference
10 мар 2022 08:00:02 Источник Nasdaq GlobeNewswire
-
02 мар 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
15 фев 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
26 янв 2022 16:01:00 Источник Nasdaq GlobeNewswire
-
Cue Biopharma to Host Business Update Call and Webcast for Ongoing CUE-101 Clinical Trials
20 янв 2022 08:00:01 Источник Nasdaq GlobeNewswire
-
05 янв 2022 08:00:02 Источник Nasdaq GlobeNewswire
-
Cue Biopharma Announces Appointment of Patricia Nasshorn as Chief Business Officer
15 дек 2021 08:00:01 Источник Nasdaq GlobeNewswire
-
Cue Biopharma to Present at JMP Securities Hematology and Oncology Summit
06 дек 2021 08:00:03 Источник Nasdaq GlobeNewswire
-
Cue Biopharma to Present at the Piper Sandler 33rd Annual Healthcare Conference
22 ноя 2021 08:00:02 Источник Nasdaq GlobeNewswire
-
Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in November
10 ноя 2021 08:00:01 Источник Nasdaq GlobeNewswire
-
21 окт 2021 12:00:00 Источник Nasdaq GlobeNewswire
-
04 окт 2021 08:00:01 Источник Nasdaq GlobeNewswire
-
28 сен 2021 08:00:02 Источник Nasdaq GlobeNewswire
-
Cue Biopharma Granted U.S. Patents on Lead Clinical Program Novel Drug Product Candidate CUE-101
21 сен 2021 08:00:02 Источник Nasdaq GlobeNewswire
-
Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences
09 сен 2021 08:00:02 Источник Nasdaq GlobeNewswire
-
17 авг 2021 16:01:00 Источник Nasdaq GlobeNewswire
-
Cue Biopharma to Host Business Update Call and Webcast
10 авг 2021 08:00:01 Источник Nasdaq GlobeNewswire
-
Cue Biopharma to Present Corporate Update at the Upcoming BTIG Virtual Biotechnology Conference
03 авг 2021 08:01:12 Источник Nasdaq GlobeNewswire